Effects of a comprehensive antimicrobial stewardship program in a surgical intensive care unit
- Authors
- Kim, Si-Ho; Yoon, Jin Gu; Park, Hyo Jung; Won, Hojeong; Ryoo, Sung Suk; Choi, Eunsil; Park, Eun-Kyung; Huh, Kyungmin; Park, Chi-Min
- Issue Date
- Jul-2021
- Publisher
- ELSEVIER SCI LTD
- Keywords
- Antimicrobial stewardship; Drug resistance; Microbial; Critical care; Mortality
- Citation
- INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, v.108, pp 237 - 243
- Pages
- 7
- Indexed
- SCIE
SCOPUS
- Journal Title
- INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Volume
- 108
- Start Page
- 237
- End Page
- 243
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/54105
- DOI
- 10.1016/j.ijid.2021.02.082
- ISSN
- 1201-9712
1878-3511
- Abstract
- Objectives: We evaluated the effects of a comprehensive antimicrobial stewardship program (ASP) in a surgical intensive care unit (SICU). Methods: The ASP was implemented from March 2018 to February 2019 at an SICU in a teaching hospital. An infectious disease physician and a pharmacist visited the SICU 3 times per week for prospective audit and feedback. Outcomes were compared between the ASP period and the same months in the preceding year (pre-ASP period). The primary outcome measure was the use of anti-pseudomonal beta-lactams (APBL). Appropriate antimicrobial de-escalation and ICU mortality rates were also compared. Results: A total of 182 and 149 patients were included in the study for the pre-ASP and ASP periods, respectively. Although disease severity was higher in the ASP group (septic shock 39.0% in pre-ASP vs 65.1% in ASP group, P < 0.001), the use of APBL as a definitive treatment was lower during ASP (68.7% vs 57.7%, OR 0.62, 95% CI 0.40-0.98). Appropriate antimicrobial de-escalation improved (63.2% vs 94.6%, P < 0.001). ICU mortality was comparable (7.7% vs 7.4%) and significantly lower during the ASP, after adjustment (adjusted OR 0.41, 95% CI 0.18-0.92, P = 0.032). Conclusions: A comprehensive ASP decreased the use of APBL and was associated with improved patient outcomes. (c) 2021 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 2. Clinical Science > Department of Infectious Diseases > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.